Literature DB >> 18854515

Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis.

M A Gonzalez-Gay, M T Garcia-Unzueta, A Berja, T R Vazquez-Rodriguez, C Gonzalez-Juanatey, J M de Matias, J Martin, P H Dessein, J Llorca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18854515     DOI： 10.1136/ard.2008.088773

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

1.  TNFα blockade for inflammatory rheumatic diseases is associated with a significant gain in android fat mass and has varying effects on adipokines: a 2-year prospective study.

Authors:  Éric Toussirot; Laurent Mourot; Barbara Dehecq; Daniel Wendling; Émilie Grandclément; Gilles Dumoulin
Journal:  Eur J Nutr       Date:  2013-10-31       Impact factor: 5.614

Review 2.  The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism.

Authors:  Mark D DeBoer
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Functional capacity in rheumatoid arthritis patients: comparison between Spanish and Brazilian sample.

Authors:  Maiza Ritomy Ide; Miguel A Gonzalez-Gay; Kelly Cristina Yano; Marcelo Jun Imai; Mario Chueire de Andrade; Javier Llorca
Journal:  Rheumatol Int       Date:  2009-12-13       Impact factor: 2.631

4.  Biologic Agents Are Associated with Excessive Weight Gain in Children with Inflammatory Bowel Disease.

Authors:  Leonard Haas; Rachel Chevalier; Brittny T Major; Felicity Enders; Seema Kumar; Jeanne Tung
Journal:  Dig Dis Sci       Date:  2017-09-11       Impact factor: 3.199

5.  Serum ghrelin in female patients with rheumatoid arthritis during treatment with infliximab.

Authors:  Michal Magiera; Magdalena Kopec-Medrek; Małgorzata Widuchowska; Anna Kotulska; Tomasz Dziewit; Damian Ziaja; Eugene J Kucharz; Beata Logiewa-Bazger; Wlodzimierz Mazur
Journal:  Rheumatol Int       Date:  2011-12-24       Impact factor: 2.631

6.  Response to 'Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomized study over 21 months'.

Authors:  Miguel A Gonzalez-Gay; Carlos Gonzalez-Juanatey; Jose A Miranda-Filloy; Javier Martin; Maria T Garcia-Unzueta; Javier Llorca
Journal:  Arthritis Res Ther       Date:  2011-04-27       Impact factor: 5.156

Review 7.  Adipokines, biomarkers of endothelial activation, and metabolic syndrome in patients with ankylosing spondylitis.

Authors:  Fernanda Genre; Raquel López-Mejías; José A Miranda-Filloy; Begoña Ubilla; Beatriz Carnero-López; Ricardo Blanco; Trinitario Pina; Carlos González-Juanatey; Javier Llorca; Miguel A González-Gay
Journal:  Biomed Res Int       Date:  2014-03-18       Impact factor: 3.411

Review 8.  Genetic markers of cardiovascular disease in rheumatoid arthritis.

Authors:  Luis Rodríguez-Rodríguez; Raquel López-Mejías; Mercedes García-Bermúdez; Carlos González-Juanatey; Miguel A González-Gay; Javier Martín
Journal:  Mediators Inflamm       Date:  2012-08-02       Impact factor: 4.711

9.  High body mass index is not associated with increased treatment failure in infliximab treated pediatric patients with inflammatory bowel disease.

Authors:  Isaac Rodin; Justin Chan; Laura Meleady; Clare Hii; Sally Lawrence; Kevan Jacobson
Journal:  JGH Open       Date:  2019-11-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.